Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 Jul:106:74-84.
doi: 10.1016/j.neuropharm.2015.08.013. Epub 2015 Aug 11.

Histamine and the striatum

Affiliations
Review

Histamine and the striatum

J Paul Bolam et al. Neuropharmacology. 2016 Jul.

Abstract

The neuromodulator histamine is released throughout the brain during periods of wakefulness. Combined with an abundant expression of histamine receptors, this suggests potential widespread histaminergic control of neural circuit activity. However, the effect of histamine on many of these circuits is unknown. In this review we will discuss recent evidence for histaminergic modulation of the basal ganglia circuitry, and specifically its main input nucleus; the striatum. Furthermore, we will discuss recent findings of histaminergic dysfunction in several basal ganglia disorders, including in Parkinson's disease and most prominently, in Tourette's syndrome, which has led to a resurgence of interest in this neuromodulator. Combined, these recent observations not only suggest a central role for histamine in modulating basal ganglia activity and behaviour, but also as a possible target in treating basal ganglia disorders. This article is part of the Special Issue entitled 'Histamine Receptors'.

Keywords: Basal ganglia; Histamine; Parkinson's disease; Striatum; Tourette's syndrome.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(A) A simplified, schematic diagram of the basal ganglia (within the pale blue box) and their associated structures. Glutamatergic connections are in red, GABAergic connections are in dark blue, dopaminergic connections are in yellow and histaminergic projections are in purple. The major excitatory afferents to the basal ganglia are from the cortex and thalamus and are directed to both the striatum and the subthalamic nucleus (STN). The striatum influences the basal ganglia output nuclei substantia nigra pars reticulata (SNr) and the internal segment of the globus pallidus (GPi) directly, or indirectly via connections with the network between the STN and external globus pallidus (GPe). The dopaminergic substantia nigra pars compacta (SNc) influences the operation of the basal ganglia via connections with each nucleus. Similarly, the histaminergic tuberomamillary nucleus (TMN) influences the basal ganglia as well as the input structures to the basal ganglia. The major targets of the basal ganglia output nuclei are the thalamus and the midbrain and brainstem premotor regions, which influence movement via direct or indirect connections with motor nuclei. (B) Histaminergic neurons located in the tuberomamillary nucleus project to nearly all regions of the brain. Emphasized here are the histaminergic projections to basal ganglia, in particular the striatum (blue), and the input structures to the basal ganglia, namely the cortex and thalamus. The histaminergic neurons fire at high frequency during wakefulness and are virtually silent during sleep.

References

    1. Adachi N., Itoh Y., Oishi R., Saeki K. Direct evidence for increased continuous histamine release in the striatum of conscious freely moving rats produced by middle cerebral artery occlusion. J. Cereb. Blood Flow Metab. 1992;12:477–483. - PubMed
    1. Airaksinen M.S., Panula P. The histaminergic system in the guinea pig central nervous system: an immunocytochemical mapping study using an antiserum against histamine. J. Comp. Neurol. 1988;273:163–186. - PubMed
    1. Alexander G.E., DeLong M.R., Strick P.L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 1986;9:357–381. - PubMed
    1. Amphoux A., Vialou V., Drescher E., Bruss M., Mannoury La Cour C., Rochat C., Millan M.J., Giros B., Bonisch H., Gautron S. Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain. Neuropharmacology. 2006;50:941–952. - PubMed
    1. Anaclet C., Parmentier R., Ouk K., Guidon G., Buda C., Sastre J.P., Akaoka H., Sergeeva O.A., Yanagisawa M., Ohtsu H., Franco P., Haas H.L., Lin J.S. Orexin/hypocretin and histamine: distinct roles in the control of wakefulness demonstrated using knock-out mouse models. J. Neurosci. 2009;29:14423–14438. - PMC - PubMed

Publication types